These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 9591628)
41. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma. Leung TH; Wong N; Lai PB; Chan A; To KF; Liew CT; Lau WY; Johnson PJ Mod Pathol; 2002 Nov; 15(11):1213-20. PubMed ID: 12429801 [TBL] [Abstract][Full Text] [Related]
42. Association of chromosome 11 locus D11S12 with histology, stage, and metastases in lung cancer. Bepler G; Fong KM; Johnson BE; O'Briant KC; Daly LA; Zimmerman PV; Garcia-Blanco MA; Peterson B Cancer Detect Prev; 1998; 22(1):14-9. PubMed ID: 9466044 [TBL] [Abstract][Full Text] [Related]
43. Mapping of genetic deletions on the long arm of chromosome 22 in human pancreatic adenocarcinomas. Handel-Fernandez ME; Nassiri M; Arana M; Perez MM; Fresno M; Nadji M; Vincek V Anticancer Res; 2000; 20(6B):4451-6. PubMed ID: 11205287 [TBL] [Abstract][Full Text] [Related]
44. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q. Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913 [TBL] [Abstract][Full Text] [Related]
45. Loss of heterozygosity on chromosome arm 11q in lung carcinoids. Petzmann S; Ullmann R; Klemen H; Renner H; Popper HH Hum Pathol; 2001 Mar; 32(3):333-8. PubMed ID: 11274644 [TBL] [Abstract][Full Text] [Related]
46. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3. Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414 [TBL] [Abstract][Full Text] [Related]
47. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis]. Xu XF; Tang PZ; Cheng SJ Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701 [TBL] [Abstract][Full Text] [Related]
48. Chromosome bands 3p14.2, 9p21, and 13q14 are frequently deleted in roentgenographically occult bronchogenic squamous cell carcinoma of the lung. Sato M; Sakurada A; Sagawa M; Endo C; Tanita T; Kondo T; Tsuchiya E; Fujimura S; Horii A Genes Chromosomes Cancer; 1998 Dec; 23(4):367-70. PubMed ID: 9824211 [TBL] [Abstract][Full Text] [Related]
49. Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. Shivapurkar N; Maitra A; Milchgrub S; Gazdar AF Hum Pathol; 2001 Feb; 32(2):169-77. PubMed ID: 11230704 [TBL] [Abstract][Full Text] [Related]
50. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors. Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193 [TBL] [Abstract][Full Text] [Related]
51. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631 [TBL] [Abstract][Full Text] [Related]
52. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945 [TBL] [Abstract][Full Text] [Related]
53. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer. Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258 [TBL] [Abstract][Full Text] [Related]
54. Loss of heterozygosity in primary lung cancer using laser capture microdissection and WAVE DNA fragment analysis techniques. Zhu W; Zou H; Beck A; Chervinsky D; Malik D; Brooks J; Tan D Med Sci Monit; 2002 Mar; 8(3):BR95-9. PubMed ID: 11889456 [TBL] [Abstract][Full Text] [Related]
55. Growth inhibition of a human lung adenocarcinoma cell line by genetic complementation with chromosome 11. O'Briant K; Jolicoeur E; Garst J; Campa M; Schreiber G; Bepler G Anticancer Res; 1997; 17(5A):3243-51. PubMed ID: 9413155 [TBL] [Abstract][Full Text] [Related]
56. Identification of a 700-kb region of common allelic loss in chromosome bands 3p14.3-p21.1 in human renal cell carcinoma. Orikasa K; Orikasa S; Horii A Cancer Genet Cytogenet; 1998 Jul; 104(2):104-10. PubMed ID: 9666802 [TBL] [Abstract][Full Text] [Related]
57. Identification of a 1-Mb common region at 16q24.1-24.2 deleted in hepatocellular carcinoma. Bando K; Nagai H; Matsumoto S; Koyama M; Kawamura N; Tajiri T; Onda M; Emi M Genes Chromosomes Cancer; 2000 May; 28(1):38-44. PubMed ID: 10738301 [TBL] [Abstract][Full Text] [Related]
58. Identification of a 100-kb region of common allelic loss on chromosome bands 10q25-q26 in human endometrial cancer. Yamakawa H; Nagase S; Yuki M; Shiwaku HO; Furukawa T; Yoshinaga K; Soeda E; Hoshi M; Hayashi Y; Sato S; Yajima A; Horii A Genes Chromosomes Cancer; 1998 Sep; 23(1):74-7. PubMed ID: 9714001 [TBL] [Abstract][Full Text] [Related]
59. Downregulated Expression of WWOX in Cervical Carcinoma: A Case-Control Study. Srivastava S; Shahi UP; Divya A; Gupta S; Singh I; Roy JK Int J Mol Cell Med; 2020; 9(4):273-288. PubMed ID: 33688485 [TBL] [Abstract][Full Text] [Related]
60. Altered expression of 17‑β‑hydroxysteroid dehydrogenase type 2 and its prognostic significance in non‑small cell lung cancer. Drzewiecka H; Jarmołowska-Jurczyszyn D; Kluk A; Gałęcki B; Dyszkiewicz W; Jagodziński PP Int J Oncol; 2020 Jun; 56(6):1352-1372. PubMed ID: 32236582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]